Overview

ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study

Status:
Unknown status
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
ACTHAR Gel has activity in sarcoidosis associated hypercalciuria and calcium dysregulation.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Albany Medical College
Treatments:
Adrenocorticotropic Hormone
beta-Endorphin
Calcium, Dietary
Hormones
Melanocyte-Stimulating Hormones